Did you know? The transformative effects of GLP-1 agonists are potent allies not only in the fight against diabetes but also key to unlocking weight loss potential in a clinical setting. In this episode, Dr. Angela Kwong, a General Practitioner with a special interest in medically supervised weight loss discusses medical weight loss, particularly through exploring the benefits and mechanisms of GLP-1 agonist drugs, which have been effective in aiding weight management and even diabetes control. Comparing the outcomes of GLP-1 drugs with those of bariatric surgery, Dr. Kwong assesses their efficacy, seeking to understand the complex relationship between pharmacological interventions and surgical options. Dr. Kwong's approach involves thorough assessments of patients' medical histories and medications to tailor treatments and manage expectations. Recognizing the dynamic nature of patient commitment, she supports those reconsidering medications and addresses the challenges of hunger and behavioral change to mitigate muscle loss. Catering to varied patient circumstances, Dr. Kwong is committed to enhancing weight loss outcomes with a comprehensive array of interventions. Tune in to our latest episode featuring Dr. Angela Kwong, as she dive into the benefits, mechanisms, and efficacy of these treatments. Don't miss out on optimizing your weight loss journey—listen now!See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related